Table 3.
Ln hsCRP and demographics and clinical characteristics.
| Mean hsCRP (mg/L) | Mean Ln hsCRP§ | 95% Confidence Intervals of Ln hsCRP | ||
|---|---|---|---|---|
| Race** | Caucasian | 1.63 | 7.40 | 7.25 – 7.54 |
| African American | 2.76 | 7.93 | 7.78 – 8.07 | |
|
| ||||
| Gender** | Male | 1.65 | 7.41 | 7.25 – 7.57 |
| Female | 2.51 | 7.83 | 7.69 – 7.97 | |
|
| ||||
| Chronic Pulmonary Disease* | No | 2.01 | 7.61 | 7.50 – 7.72 |
| Yes | 3.19 | 8.07 | 7.73 – 8.40 | |
|
| ||||
| Cardiovascular Disease | No | 2.03 | 7.62 | 7.50 – 7.74 |
| Yes | 2.37 | 7.77 | 7.54 – 8.00 | |
|
| ||||
| Hypertension** | No | 1.77 | 7.48 | 7.35 – 7.61 |
| Yes | 2.80 | 7.94 | 7.77 – 8.11 | |
|
| ||||
| Use of Pain Medication* | No | 1.86 | 7.53 | 7.40 – 7.66 |
| Yes | 2.64 | 7.88 | 7.71 – 8.05 | |
|
| ||||
| Smoking | No | 2.18 | 7.69 | 7.57 – 7.81 |
| Yes | 1.76 | 7.47 | 7.23 – 7.71 | |
|
| ||||
| Diabetes** | No | 1.94 | 7.57 | 7.46 – 7.68 |
| Yes | 3.64 | 8.20 | 7.92 – 8.49 | |
|
| ||||
| Insulin Use* | No | 2.02 | 7.61 | 7.50 – 7.72 |
| Yes | 3.86 | 8.26 | 7.84 – 8.68 | |
Ln hsCRP = natural logarithm of high-sensitivity C-reactive protein in serum (§for presentation purposes, hsCRP was expressed in μg/L prior to natural log transformation)
p < 0.05 compared to referent;
p < 0.0001 compared to referent